Imelda | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition	Active, not recruiting	Phase 3	2026-09-30		NCT05567796
Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation	Arrhythmias, Cardiac, Arterial Occlusive Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atrial fibrillation, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder	Recruiting	Phase 4	2026-09-15		NCT07405671
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition	Recruiting	Phase 3	2026-09-09		NCT07770841
The Added Value of Tissue or Liquid Biopsy NGS Profiling in Advanced Solid Tumor Treatment Decisions.	Advanced Solid Tumor Cancer; Primary CNS Tumors	Recruiting	Not stated	2026-07-20		NCT07713550
Evaluation of Calcified Coronary Lesion Preparation With the Naviscore Scoring Balloon	Calcific Coronary Arteriosclerosis; Coronary Arterial Disease (CAD)	Not yet recruiting	Not applicable	2026-06-16		NCT07650578
Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention	Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder	Recruiting	Phase 3	2024-03-08		NCT06095765